Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports

Seunghee Na; Taewon Kim

doi:10.1007/s10072-021-05368-y

Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports

Seunghee Na
, Taewon Kim

Department of Neurology

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	3897-3899
Number of pages	3
Journal	Neurological Sciences
Volume	42
Issue number	9
DOIs	https://doi.org/10.1007/s10072-021-05368-y
State	Published - Sep 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s10072-021-05368-y

Cite this

@article{d60d8ca4cac0408a8787988edeecae2c,

title = "Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports",

author = "Seunghee Na and Taewon Kim",

year = "2021",

month = sep,

doi = "10.1007/s10072-021-05368-y",

language = "English",

volume = "42",

pages = "3897--3899",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

number = "9",

}

TY - JOUR

T1 - Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation

T2 - three case reports

AU - Na, Seunghee

AU - Kim, Taewon

PY - 2021/9

Y1 - 2021/9

UR - https://www.scopus.com/pages/publications/85107421961

U2 - 10.1007/s10072-021-05368-y

DO - 10.1007/s10072-021-05368-y

M3 - Letter

C2 - 34085110

AN - SCOPUS:85107421961

SN - 1590-1874

VL - 42

SP - 3897

EP - 3899

JO - Neurological Sciences

JF - Neurological Sciences

IS - 9

ER -

Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports

UN SDGs

Access to Document

Other files and links

Cite this